Home
/

PCOS and Insulin Resistance: How It Affects Your Weight

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Key takeaway:

Insulin resistance forces the pancreas to overproduce insulin, which promotes abdominal fat storage and simultaneously drives excess androgen production in the ovaries while suppressing SHBG — increasing free testosterone. This creates a self-reinforcing cycle where insulin resistance worsens androgens and androgens worsen insulin resistance. Improving insulin sensitivity is the central lever for both weight and hormonal outcomes in PCOS.

Read more →
Table of contents

You're eating less, moving more, and the scale won't budge. Or worse, it's climbing. If you have polycystic ovary syndrome, this isn't a failure of willpower. It's a metabolic problem with a specific mechanism: insulin resistance. When your cells stop responding to insulin the way they should, your body compensates by making more. That extra insulin doesn't just manage blood sugar. It signals fat storage, raises androgen levels, and makes weight loss feel nearly impossible. Understanding how insulin resistance fuels PCOS weight gain is the first step toward addressing it.

What Insulin Resistance Actually Does in PCOS

Insulin is a hormone that helps glucose move from your bloodstream into your cells, where it's used for energy. In insulin resistance, your cells become less responsive to insulin's signal. Your pancreas compensates by producing more insulin to get the job done. This state of elevated insulin, called hyperinsulinemia, is where the metabolic trouble begins.

The excess insulin doesn't just affect blood sugar. It directly stimulates the ovaries to produce more androgens, particularly testosterone. Higher androgen levels disrupt ovulation, contribute to symptoms like acne and excess hair growth, and interfere with the body's ability to regulate fat storage. Insulin also reduces the production of sex hormone-binding globulin (SHBG), a protein that normally binds to testosterone and keeps it inactive. With less SHBG, more free testosterone circulates, amplifying the hormonal imbalance.

This creates a cycle: insulin resistance raises insulin, insulin raises androgens, and androgens worsen insulin resistance. The result is a metabolic environment that favors weight gain and makes weight loss significantly harder.

How Insulin Resistance Affects Metabolism, Hormones, and Fat Storage

Metabolic rate and energy expenditure

Insulin resistance slows your metabolic rate by impairing how efficiently your body uses glucose for energy. When cells resist insulin, glucose stays in the bloodstream longer, and your body shifts toward storing energy as fat rather than burning it. This metabolic slowdown means you burn fewer calories at rest, even if your activity level hasn't changed.

Hormonal disruption and androgen excess

Elevated insulin stimulates the ovaries to overproduce androgens, particularly testosterone. At the same time, insulin suppresses SHBG production in the liver, leaving more testosterone unbound and biologically active. This hormonal imbalance disrupts ovulation, contributes to irregular periods, and drives symptoms like hirsutism and acne. High androgens also promote fat accumulation in the abdominal area, a pattern associated with greater metabolic risk.

Fat storage and body composition

Insulin is a fat-storage hormone. When insulin levels are chronically elevated, your body preferentially stores fat, particularly visceral fat around the abdomen. This type of fat is metabolically active and releases inflammatory molecules that further worsen insulin resistance. Women with PCOS often experience weight gain concentrated in the midsection, even when total body weight remains stable. This shift in body composition increases the risk of metabolic syndrome, cardiovascular disease, and type 2 diabetes.

Appetite regulation and cravings

Insulin resistance disrupts the signaling of leptin, a hormone that regulates hunger and satiety. When leptin signaling is impaired, your brain doesn't receive the message that you're full, leading to increased appetite and cravings, particularly for carbohydrates. This makes it harder to maintain a caloric deficit, even when you're consciously trying to eat less.

Why PCOS Makes Insulin Resistance Worse

Insulin resistance in PCOS is driven by a combination of genetic predisposition, hormonal imbalances, inflammation, and lifestyle factors. Genetics play a role in how your body processes insulin and stores fat. If you have a family history of type 2 diabetes or metabolic syndrome, your risk of developing insulin resistance is higher.

Excess body weight, particularly visceral fat, worsens insulin resistance by releasing inflammatory cytokines that interfere with insulin signaling. However, insulin resistance can occur in lean women with PCOS as well, suggesting that hormonal factors independent of weight contribute to the condition. Elevated androgens themselves impair insulin sensitivity, creating a feedback loop where high testosterone worsens insulin resistance, and high insulin raises testosterone.

Chronic low-grade inflammation is another driver. Women with PCOS often have elevated levels of C-reactive protein (CRP) and other inflammatory markers, which interfere with insulin receptor function. Dietary patterns high in refined carbohydrates and added sugars exacerbate insulin resistance by causing repeated spikes in blood glucose and insulin. Over time, this constant demand on the pancreas leads to worsening insulin resistance and, in some cases, progression to prediabetes or type 2 diabetes.

Why Weight Loss Is Harder With PCOS and Insulin Resistance

Weight loss in PCOS is harder because the metabolic environment actively resists it. High insulin levels promote fat storage and inhibit fat breakdown, a process called lipolysis. When insulin is elevated, your body stays in storage mode rather than burning stored fat for energy. This makes it difficult to lose weight even in a caloric deficit.

Hormonal imbalances compound the problem. Elevated androgens shift body composition toward more fat and less muscle. Muscle tissue is metabolically active and burns more calories at rest, so losing muscle mass further slows your metabolic rate. Women with PCOS also experience greater metabolic adaptation during weight loss, meaning their bodies reduce energy expenditure more than expected for the amount of weight lost. This adaptive response makes it harder to sustain weight loss over time.

Individual variation in insulin sensitivity, androgen levels, and inflammatory markers means that the same dietary or exercise intervention produces different results in different women. Some women with PCOS respond well to moderate carbohydrate restriction, while others see better results with higher fiber intake and balanced macronutrients. Tracking biomarkers like fasting insulin, triglyceride-glucose index, and leptin can help identify which approach is working for your specific metabolic profile.

Using Biomarkers to Guide Your PCOS Approach

Measuring insulin resistance and metabolic health over time gives you a clearer picture of what's working. Fasting insulin is one of the most direct markers of insulin resistance. While there is no universally agreed clinical cutoff, many practitioners consider levels above 10 µIU/mL as a potential indicator of insulin resistance, even if fasting glucose is still normal. The threshold varies by population and assay method. Hemoglobin A1c reflects average blood sugar over the past three months and helps identify prediabetes or diabetes risk. The triglyceride-glucose index, calculated from fasting triglycerides and glucose, is a validated marker of insulin resistance that correlates well with more complex tests.

Other useful markers include adiponectin, a hormone produced by fat cells that improves insulin sensitivity. Lower adiponectin levels are associated with greater insulin resistance. Leptin levels reflect both fat mass and leptin resistance. High leptin with persistent hunger suggests impaired leptin signaling. Tracking testosterone, SHBG, and the free androgen index helps assess hormonal balance and response to treatment.

Monitoring these markers every three to six months allows you to see whether dietary changes, exercise, or other interventions are improving insulin sensitivity and metabolic health. Directionality matters more than any single value. If fasting insulin is trending down and adiponectin is rising, you're moving in the right direction, even if weight loss is slower than expected.

If you're managing PCOS and insulin resistance, Superpower's 100+ biomarker panel can show you exactly where your metabolism and hormones stand, so you're adjusting based on data, not guesswork.

FAQs

Foods that improve insulin sensitivity include non-starchy vegetables like leafy greens, broccoli, and cauliflower, which are high in fiber and low in glycemic load. Lean proteins such as fish, chicken, eggs, and legumes help stabilize blood sugar and support muscle mass. Healthy fats from sources like olive oil, avocados, nuts, and fatty fish provide anti-inflammatory benefits and improve insulin signaling. Whole grains like quinoa, oats, and barley offer fiber that slows glucose absorption. Berries are lower in sugar than other fruits and rich in antioxidants that reduce inflammation.
A PCOS insulin resistance diet prioritizes blood sugar control and hormonal balance, not just calorie reduction. It emphasizes low-glycemic carbohydrates, adequate protein to preserve muscle mass, and anti-inflammatory fats. Meal timing and carbohydrate distribution matter because insulin sensitivity varies throughout the day. Many women with PCOS benefit from eating more carbohydrates earlier in the day when insulin sensitivity is higher. The goal is to reduce insulin spikes, lower chronic insulin levels, and improve metabolic flexibility, which supports both weight loss and hormonal regulation.
Yes, approximately 30 to 50 percent of women with PCOS do not have insulin resistance. These women may have PCOS driven primarily by other factors, such as elevated luteinizing hormone, genetic predisposition, or adrenal androgen excess. However, even in lean women without overt insulin resistance, subtle metabolic dysfunction may still be present. Testing fasting insulin, glucose, and other metabolic markers helps determine whether insulin resistance is a factor in your specific case.
Women with PCOS have a significantly elevated risk of developing type 2 diabetes, with meta-analyses showing they are approximately three to four times more likely to develop the condition compared to women without PCOS, though the risk varies by ethnicity, BMI, and study design. The risk is highest in women with insulin resistance, obesity, or a family history of diabetes. Regular screening with fasting glucose, hemoglobin A1c, and insulin levels is essential for early detection and intervention.
Weight loss can significantly improve insulin sensitivity in women with PCOS, but it doesn't always improve insulin resistance completely. Even modest weight loss of 5 to 10 percent of body weight can lower insulin levels, improve ovulation, and reduce androgen levels. However, the degree of improvement varies based on genetics, baseline insulin resistance, and body composition changes. Losing fat while preserving or building muscle produces better metabolic outcomes than weight loss alone.
Inositol, particularly myo-inositol and D-chiro-inositol, improves insulin sensitivity and ovulation in women with PCOS. Berberine activates AMPK, a cellular energy sensor that improves glucose uptake and insulin sensitivity. Magnesium supports insulin signaling and is often deficient in women with PCOS. Omega-3 fatty acids reduce inflammation and improve metabolic markers. Vitamin D deficiency is common in PCOS and correcting it may improve insulin sensitivity. Supplements work best alongside dietary and lifestyle changes, not as replacements.

References

  1. Anagnostis, P., Paparodis, R. D., Bosdou, J. K., Bothou, C., Macut, D., Goulis, D. G., & Livadas, S. (2021). Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies. Endocrine, 74(2), 245-253. https://doi.org/10.1007/s12020-021-02801-2

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey